BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28069650)

  • 1. Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia.
    Caffrey AR; Timbrook TT; Noh E; Sakoulas G; Opal SM; Nizet V; LaPlante KL
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort study.
    López-Cortés LE; Gálvez-Acebal J; Del Toro MD; Velasco C; de Cueto M; Caballero FJ; Muniain MA; Pascual A; Rodríguez-Baño J
    PLoS One; 2013; 8(12):e82958. PubMed ID: 24376617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study.
    Rasmussen JB; Knudsen JD; Arpi M; Schønheyder HC; Benfield T; Ostergaard C
    J Antimicrob Chemother; 2014 Feb; 69(2):506-14. PubMed ID: 24078468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology.
    Schreiber MP; Chan CM; Shorr AF
    J Crit Care; 2011 Aug; 26(4):395-401. PubMed ID: 21036521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.
    Wi YM; Kim JM; Joo EJ; Ha YE; Kang CI; Ko KS; Chung DR; Song JH; Peck KR
    Int J Antimicrob Agents; 2012 Aug; 40(2):108-13. PubMed ID: 22633565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton-pump inhibitors do not influence clinical outcomes in patients with
    Caffrey AR; Timbrook TT; Ali SR; Nizet V; Sakoulas G
    Therap Adv Gastroenterol; 2019; 12():1756284819834273. PubMed ID: 30923573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins and outcomes in patients with bloodstream infection: a propensity-matched analysis.
    Leung S; Pokharel R; Gong MN
    Crit Care Med; 2012 Apr; 40(4):1064-71. PubMed ID: 22202711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of penicillin, dicloxacillin and cefuroxime for penicillin-susceptible Staphylococcus aureus bacteraemia: a retrospective, propensity-score-adjusted case-control and cohort analysis.
    Nissen JL; Skov R; Knudsen JD; Ostergaard C; Schønheyder HC; Frimodt-Møller N; Benfield T
    J Antimicrob Chemother; 2013 Aug; 68(8):1894-900. PubMed ID: 23599360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of linezolid and vancomycin among a national veterans affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
    Caffrey AR; Morrill HJ; Puzniak LA; Laplante KL
    Pharmacotherapy; 2014 May; 34(5):473-80. PubMed ID: 24420846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
    Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
    Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Higher Daptomycin Dose (7 mg/kg or Greater) with Improved Survival in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Timbrook TT; Caffrey AR; Luther MK; Lopes V; LaPlante KL
    Pharmacotherapy; 2018 Feb; 38(2):189-196. PubMed ID: 29235661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study.
    Caffrey AR; Appaneal HJ; LaPlante KL; Lopes VV; Ulloa ER; Nizet V; Sakoulas G
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0211721. PubMed ID: 35416712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Novel Antistaphylococcal Ectolysin P128 in a Rat Model of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Channabasappa S; Durgaiah M; Chikkamadaiah R; Kumar S; Joshi A; Sriram B
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180523
    [No Abstract]   [Full Text] [Related]  

  • 15. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP; Zhao JJ; Davis SL; Kullar R; Kaye KS; Lephart P; Rybak MJ
    Clin Infect Dis; 2013 Jun; 56(11):1562-9. PubMed ID: 23449272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
    Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
    Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections.
    Song KH; Kim M; Kim CJ; Cho JE; Choi YJ; Park JS; Ahn S; Jang HC; Park KH; Jung SI; Yoon N; Kim DM; Hwang JH; Lee CS; Lee JH; Kwak YG; Kim ES; Park SY; Park Y; Lee KS; Lee YS; Kim HB
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.
    Goto M; Schweizer ML; Vaughan-Sarrazin MS; Perencevich EN; Livorsi DJ; Diekema DJ; Richardson KK; Beck BF; Alexander B; Ohl ME
    JAMA Intern Med; 2017 Oct; 177(10):1489-1497. PubMed ID: 28873140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose Acetylsalicylic Acid Treatment and Impact on Short-Term Mortality in Staphylococcus aureus Bloodstream Infection: A Propensity Score-Matched Cohort Study.
    Osthoff M; Sidler JA; Lakatos B; Frei R; Dangel M; Weisser M; Battegay M; Widmer AF
    Crit Care Med; 2016 Apr; 44(4):773-81. PubMed ID: 26741577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
    Parta M; Goebel M; Thomas J; Matloobi M; Stager C; Musher DM
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1043-8. PubMed ID: 20731594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.